226 related articles for article (PubMed ID: 29346471)
1. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
van Veen EM; Brentnall AR; Byers H; Harkness EF; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
JAMA Oncol; 2018 Apr; 4(4):476-482. PubMed ID: 29346471
[TBL] [Abstract][Full Text] [Related]
2. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
[TBL] [Abstract][Full Text] [Related]
3. A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
Brentnall AR; van Veen EM; Harkness EF; Rafiq S; Byers H; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
Int J Cancer; 2020 Apr; 146(8):2122-2129. PubMed ID: 31251818
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
[TBL] [Abstract][Full Text] [Related]
5. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
Brentnall AR; Harkness EF; Astley SM; Donnelly LS; Stavrinos P; Sampson S; Fox L; Sergeant JC; Harvie MN; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Howell A; Cuzick J; Evans DG
Breast Cancer Res; 2015 Dec; 17(1):147. PubMed ID: 26627479
[TBL] [Abstract][Full Text] [Related]
6. A comparison of five methods of measuring mammographic density: a case-control study.
Astley SM; Harkness EF; Sergeant JC; Warwick J; Stavrinos P; Warren R; Wilson M; Beetles U; Gadde S; Lim Y; Jain A; Bundred S; Barr N; Reece V; Brentnall AR; Cuzick J; Howell T; Evans DG
Breast Cancer Res; 2018 Feb; 20(1):10. PubMed ID: 29402289
[TBL] [Abstract][Full Text] [Related]
7. The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.
Evans DG; Brentnall A; Byers H; Harkness E; Stavrinos P; Howell A; ; Newman WG; Cuzick J
J Med Genet; 2017 Feb; 54(2):111-113. PubMed ID: 27794048
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk.
Kerlikowske K; Ichikawa L; Miglioretti DL; Buist DS; Vacek PM; Smith-Bindman R; Yankaskas B; Carney PA; Ballard-Barbash R;
J Natl Cancer Inst; 2007 Mar; 99(5):386-95. PubMed ID: 17341730
[TBL] [Abstract][Full Text] [Related]
9. The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?
Evans DG; van Veen EM; Byers H; Roberts E; Howell A; Howell SJ; Harkness EF; Brentnall A; Cuzick J; Newman WG
Int J Cancer; 2022 Jan; 150(1):73-79. PubMed ID: 34460111
[TBL] [Abstract][Full Text] [Related]
10. An alternative approach to selecting patients for high-risk screening with breast MRI.
Hollingsworth AB; Stough RG
Breast J; 2014; 20(2):192-7. PubMed ID: 24387050
[TBL] [Abstract][Full Text] [Related]
11. Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I.
Warwick J; Birke H; Stone J; Warren RM; Pinney E; Brentnall AR; Duffy SW; Howell A; Cuzick J
Breast Cancer Res; 2014 Oct; 16(5):451. PubMed ID: 25292294
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent effect of mammographic breast density on the risk of contralateral breast cancer.
Chowdhury M; Euhus D; O'Donnell M; Onega T; Choudhary PK; Biswas S
Breast Cancer Res Treat; 2018 Jul; 170(1):143-148. PubMed ID: 29511964
[TBL] [Abstract][Full Text] [Related]
13. Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.
Malkov S; Shepherd JA; Scott CG; Tamimi RM; Ma L; Bertrand KA; Couch F; Jensen MR; Mahmoudzadeh AP; Fan B; Norman A; Brandt KR; Pankratz VS; Vachon CM; Kerlikowske K
Breast Cancer Res; 2016 Dec; 18(1):122. PubMed ID: 27923387
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer.
Eriksson M; Czene K; Vachon C; Conant EF; Hall P
J Clin Oncol; 2023 May; 41(14):2536-2545. PubMed ID: 36930854
[TBL] [Abstract][Full Text] [Related]
15. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
[TBL] [Abstract][Full Text] [Related]
16. Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk.
Vachon CM; Scott CG; Tamimi RM; Thompson DJ; Fasching PA; Stone J; Southey MC; Winham S; Lindström S; Lilyquist J; Giles GG; Milne RL; MacInnis RJ; Baglietto L; Li J; Czene K; Bolla MK; Wang Q; Dennis J; Haeberle L; Eriksson M; Kraft P; Luben R; Wareham N; Olson JE; Norman A; Polley EC; Maskarinec G; Le Marchand L; Haiman CA; Hopper JL; Couch FJ; Easton DF; Hall P; Chatterjee N; Garcia-Closas M
Breast Cancer Res; 2019 May; 21(1):68. PubMed ID: 31118087
[TBL] [Abstract][Full Text] [Related]
17. Association of the Interaction Between Mammographic Breast Density, Body Mass Index, and Menopausal Status With Breast Cancer Risk Among Korean Women.
Tran TXM; Moon SG; Kim S; Park B
JAMA Netw Open; 2021 Dec; 4(12):e2139161. PubMed ID: 34940866
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
Evans DGR; van Veen EM; Harkness EF; Brentnall AR; Astley SM; Byers H; Woodward ER; Sampson S; Southworth J; Howell SJ; Maxwell AJ; Newman WG; Cuzick J; Howell A
Genet Med; 2022 Jul; 24(7):1485-1494. PubMed ID: 35426792
[TBL] [Abstract][Full Text] [Related]
19. Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.
Atakpa EC; Thorat MA; Cuzick J; Brentnall AR
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013091. PubMed ID: 34697802
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
